May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
ERG Analysis of the Effect of Subretinal Allele-Independent Ribozyme Injections on the Visual Responses of Wild-Type and P23H Mutant Rats
Author Affiliations & Notes
  • D.A. White
    Molecular Genetics & Microbiol, University of Florida, Gainesville, FL, United States
  • W.W. Hauswirth
    Ophthalmology; Molecular Genetics & Microbiol, University of Florida, Gainesville, FL, United States
  • A.S. Lewin
    Ophthalmology; Molecular Genetics & Microbiol, University of Florida, Gainesville, FL, United States
  • Footnotes
    Commercial Relationships  D.A. White, None; W.W. Hauswirth, Applied Genetic Technologies Corp. P; A.S. Lewin, None.
  • Footnotes
    Support  NEI R01 EY11596
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2332. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.A. White, W.W. Hauswirth, A.S. Lewin; ERG Analysis of the Effect of Subretinal Allele-Independent Ribozyme Injections on the Visual Responses of Wild-Type and P23H Mutant Rats . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2332.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Our initial efforts at treating a rat model of Autosomal Dominant Retinitis Pigmentosa (ADRP) utilized ribozymes designed to specifically cleave the mutant opsin transcript responsible for the P23H form of the disease; however, over one hundred different opsin mutations have been found to be associated with ADRP. In an attempt to avoid the problem of having to develop a different ribozyme for each disease-causing mutation, we have designed allele-independent ribozymes that target sequences conserved among wild-type and mutant forms of the disease-causing transcript. Methods: Two allele-independent ribozymes were cloned into rAAV packaging vectors under the control of a mouse opsin promoter. These vectors were packaged as recombinant AAV and injected subretinally into the right eyes of both wild-type rats and rats containing a P23H transgene. ERG analysis was performed at regular intervals to determine the effects of these ribozymes on the visual responses of the animals by comparing the ribozyme-injected right eyes with control, uninjected left eyes. Results: Subretinal injection of P23H rats with recombinant AAV expressing these allele-independent ribozymes did not alter the course of retinal degeneration based on ERG amplitudes. Similarly, the ribozymes show no effect on the ERG response of wild-type animals. Conclusions: Delivery of our allele-independent ribozymes to wild-type retinas did not cause a reduction of rhodopsin synthesis that was great enough to be deletorious to the visual response, as measured by ERG. Allele-independent ribozymes injected into P23H mutant retinas do not by themselves rescue retinal degeneration. Future studies will focus on determining the amount of rhodopsin message reduction achieved by these ribozymes, as well as on combining these ribozyme treatments with the delivery of ribozyme-resistant opsin replacement genes.

Keywords: gene transfer/gene therapy • retinal degenerations: hereditary • electroretinography: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×